Industry Payments to Physicians: Confronting Conflicts of Interest
http://www.cancerthe...article/674713/
Posted 14 July 2017 - 09:25 AM
Industry Payments to Physicians: Confronting Conflicts of Interest
http://www.cancerthe...article/674713/
08/2015 Initial PCR: 66.392%
12/2015 PCR: 1.573%
03/2016 PCR: 0.153%
06/2016 PCR: 0.070%
09/2016 PCR: 0.052%
12/2016 PCR: 0.036%
03/2017 PCR: 0.029%
06/2017 PCR: 0.028%
09/2017 PCR: 0.025%
12/2017 PCR: 0.018%
Taking Imatinib 400 mg
Posted 14 July 2017 - 09:49 AM
From r06ue1's link above:
"Even hematologist-oncologists' social media posts on Twitter might be associated with industry payments, according to a recent study.3
"The reason industry spends billions in payments to physicians is that these payments do, on average, influence choices in favor of the payer," Dr Fineberg said. "Patients are entitled to have the professional opinion and advice of doctors untainted by external influences." "
In my overseas travel experience, we called these kinds of payments - bribes.
Diagnosed 11 May 2011 (100% FiSH, 155% PCR)
with b2a2 BCR-ABL fusion transcript coding for the 210kDa BCR-ABL protein
Sprycel: 20 mg per day - taken at lights out with Quercetin and/or Magnesium Taurate
6-8 grams Curcumin C3 complex.
2015 PCR: < 0.01% (M.D. Anderson scale)
2016 PCR: < 0.01% (M.D. Anderson scale)
March 2017 PCR: 0.01% (M.D. Anderson scale)
June 2017 PCR: "undetected"
September 2017 PCR: "undetected"
Posted 14 July 2017 - 11:17 AM
Pharmaceutical companies will bring lunch for a Doctor's office with the provision that they get to give a 30 minute talk highlighting the benefits of their drugs. It is a fine line between education and improper financial incentives.
Posted 14 July 2017 - 01:18 PM
0 members, 1 guests, 0 anonymous users